Analyzing Risks of Biotech Clinical Trials Frank David, Founder of Pharmagellan

Analyzing Risks of Biotech Clinical Trials Frank David, Founder of Pharmagellan

HomeBay Bridge BioAnalyzing Risks of Biotech Clinical Trials Frank David, Founder of Pharmagellan
Analyzing Risks of Biotech Clinical Trials Frank David, Founder of Pharmagellan
ChannelPublish DateThumbnail & View CountDownload Video
Channel AvatarPublish Date not found Thumbnail
0 Views
Frank David joins us to walk through a framework for estimating the likelihood of success of clinical trials.

Check out Frank's books on analyzing clinical trials and predicting and valuing biotechnology here: https://www.pharmagellan.com/books

And check out Frank's blog post on his clinical triac risk framework here: https://www.pharmagellan.com/blog/clinical-pos

Please take the opportunity to connect and share this video with your friends and family if you find it helpful.